EUR · 1 valued
€1.39 million
Supplier · public contract awards
BG Aliud / Stadapharm GBR public contracts.
BG Aliud / Stadapharm GBR has won 91 public contracts between 2024 and 2026 from 9 public buyers in Germany. Its most frequent buyer is GWQ ServicePlus AG (35 awards). Outside TED, published values total €1.39 million across 1 award.
91Contracts won
9Public buyers
1Country
May 2026Latest award
Latest contracts won
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Colchicin, ATC M04
Awarded by DAK-Gesundheit · Germany
29 May 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pyridostigmin (aus
Awarded by DAK-Gesundheit · Germany
8 May 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Molsidomin, ATC
Awarded by DAK-Gesundheit · Germany
24 Apr 2026Awarded
Németország – Gyógyszerészeti termékek – 34. Generikaausschreibung (2/3er) - Auftragsbekanntmachung
Awarded by GWQ ServicePlus AG · Germany
13 Feb 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC
Awarded by DAK-Gesundheit · Germany
20 Jan 2026Awarded
Németország – Gyógyszerészeti termékek – Generika-Ersatzkassen 27
Awarded by DAK-Gesundheit · Germany
8 Dec 2025Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Timolol + Brinzo
Awarded by DAK-Gesundheit · Germany
29 Sep 2025Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Azelastin + Flut
Awarded by DAK-Gesundheit · Germany
29 Jul 2025Awarded
Németország – Gyógyszerészeti termékek – Generika-Ersatzkassen 24
Awarded by DAK-Gesundheit · Germany
17 Jul 2025Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.
Awarded by DAK-Gesundheit · Germany
1 Aug 2024Awarded
Contracts won by year
Contracts won by year
from the published recordsPublished value, by currency (feeds other than TED)
Typical contract size on TED
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against BG Aliud / Stadapharm GBR?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding See open tenders